2291 - 2300 of 5832 Results
Title
Year
- Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design2021OPENTitle: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial designJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 22Issue #:Start Page: 100785End Page: 100785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100785Citation Count: 13
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients2021OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 15
-
OPENTitle: Focused WorkshopsJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: S1Start Page: 23End Page: 43Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.14970Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14970Citation Count: 0
-
OPENTitle: Folded concave penalized learning of high-dimensional MRI data in Parkinson’s diseaseJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 357Issue #:Start Page: 109157End Page: 109157Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jneumeth.2021.109157Best OA location URL: http://manuscript.elsevier.com/S0165027021000923/pdf/S0165027021000923.pdfCitation Count: 1
-
OPENTitle: Proceedings of Reanimation 2021, the French Intensive Care Society International CongressJournal Name: Annals of Intensive CarePublisher: Springer Science and Business Media LLCVol: 11Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13613-021-00862-0Best OA location URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00862-0Citation Count: 7
- Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study2021OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 45
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391001Citation Count: 8
- Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brain2021OPENTitle: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brainJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 46Issue #:Start Page: 128164End Page: 128164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379902Citation Count: 13
-
OPENTitle: Thyroarytenoid Muscle Gene Expression in a Rat Model of Early‐Onset Parkinson's DiseaseJournal Name: The LaryngoscopePublisher: WileyVol: 131Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/lary.29661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595495Citation Count: 10